Brean Capital Initiates Coverage On Osiris Therapeutics
December 29, 2014 at 17:05 PM EST
Brean Capital initiated coverage on Osiris Therapeutics, Inc. (NASDAQ: OSIR) Monday with a Buy rating and $19 price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.